Isobutylmethylxanthine
IBMX
Chemical compound
IBMX (3-isobutyl-1-methylxanthine), like other methylxanthine derivatives, is both a:
- competitive non-selective phosphodiesterase inhibitor[1] which raises intracellular cAMP, activates PKA, inhibits TNFα[2][3] and leukotriene[4] synthesis, and reduces inflammation and innate immunity,[4] and
- nonselective adenosine receptor antagonist.[5]
This article may be too technical for most readers to understand. (May 2023) |
As a phosphodiesterase inhibitor, IBMX has IC50 = 2–50 μM[6] and does not inhibit PDE8 or PDE9.[7]